[Ensuring the long-term effectiveness of MS treatment].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000906:Antibodies / Q000097:blood; D006801:Humans; D007273:Injections, Intramuscular; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000276:immunology / Q000627:therapeutic use*; D008134:Long-Term Care; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000276:immunology / Q000451:nursing*; D010349:Patient Compliance; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D000906:Antibodies; D016899:Interferon-beta; D000068556:Interferon beta-1a